Search

everythinglearnresearchcommunity

for

Search:↓

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Careful management of blood thinners is crucial for lupus patients with APS.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Upadacitinib effectively treats psoriasis and lichen planus together.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Minoxidil can cause dangerous fluid buildup around the heart.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

The combination therapy was effective and well-tolerated, especially in young patients.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

A woman with Lupus Vasculitis improved after treatment with steroids and other medications.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Scalp alopecia areata mostly affects young adult males, often starts suddenly, and usually presents as single, patchy lesions.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

Early diagnosis and surgery are crucial for managing cryptorchidism and related hair loss in dogs.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Wounds on the face usually heal with scars, but understanding how some wounds heal without scars could lead to better treatments.